. 2020 Mar 3;12(3):685. doi: 10.3390/nu12030685

Table 3.

Phase 1: Hemodynamic properties and arterial stiffness.

	WKY	SHR
	Control	Control	Navy Bean	Black Bean
Hemodynamics
SBP (mmHg) ¹
Baseline	153 ± 7 ^b	197 ± 6 ^a	181 ± 8 ^a	187 ± 4 ^a
Week 4	153 ± 4 ^b	188 ± 5 ^a	194 ± 7 ^a	194 ± 5 ^a
Week 8	142 ± 6 ^b	184 ± 5 ^a	199 ± 6 ^a	199 ± 6 ^a
DBP (mmHg) ¹
Baseline	99 ± 4 ^b	149 ± 7 ^a	134 ± 8 ^a	140 ± 5 ^a
Week 4	103 ± 5 ^b	140 ± 4 ^a	145 ± 7 ^a	142 ± 7 ^a
Week 8	94 ± 4 ^b	138 ± 4 ^a	146 ± 9 ^a	144 ± 7 ^a
MAP (mmHg) ¹
Baseline	116 ± 5 ^b	165 ± 6 ^a	149 ± 8 ^a	155 ± 5 ^a
Week 4	119 ± 4 ^b	156 ± 4 ^a	161 ± 7 ^a	159 ± 6 ^a
Week 8	110 ± 5 ^b	153 ± 4 ^a	163 ± 8 ^a	162 ± 6 ^a
HR (bpm) ²
Baseline	397 ± 7	436 ± 20	435 ± 20	375 ± 7
Week 8	387 ± 14	442 ± 22	423 ± 22	423 ± 16
HRV (bpm) ²
Baseline	153 ± 2	145 ± 5	147 ± 4	162 ± 3
Week 8	158 ± 4	145 ± 6	148 ± 5	147 ± 3
Femoral artery stiffness
PFV (cm/s)
Baseline	26.4 ± 1.8	28.3 ± 0.6	27.6 ± 1.1	27.6 ± 0.9
Week 8	24.6 ± 1.3	27.9 ± 1.1	27.3 ± 1.9	27.7 ± 1.4
MinFV (cm/s)
Baseline	1.60 ± 0.78	1.90 ± 1.10	3.32 ± 0.35	2.98 ± 0.54
Week 8	2.74 ± 0.32	3.25 ± 0.73	2.00 ± 0.76	3.85 ± 0.59
MFV (cm/s)
Baseline	6.37 ± 0.59 ^b	7.44 ± 0.88 ^a,b	8.55 ± 0.44 ^a	8.67 ± 0.48 ^a
Week 8	6.85 ± 0.45	8.20 ± 0.79	7.30 ± 0.56	8.69 ± 0.72
Pulsatility index
Baseline	4.2 ± 0.4	3.7 ± 0.6	2.9 ± 0.1	3.1 ± 0.3
Week 8	2.7 ± 0.4	3.0 ± 0.3	3.3 ± 0.2	3.2 ± 0.3
Resistivity index
Baseline	0.94 ± 0.03	0.92 ± 0.03	0.88 ± 0.01	0.90 ± 0.02
Week 8	0.92 ± 0.02	0.88 ± 0.03	0.92 ± 0.03	0.87 ± 0.02

Measurements obtained from ¹ tail and ² femoral arteries. Data are expressed as mean ± SEM (n = 5–10/group). For means within the same row, different letters superscripts [a,b] represent significant differences (p < 0.05). An absence of letters indicates no statistical differences. Abbreviations: DBP, diastolic blood pressure; HR, heart rate; HRV, heart rate variability; MAP, mean arterial pressure; MinFV, minimum flow velocity; MFV, mean flow velocity; PFV, peak flow velocity.